Trial Profile
Heparin with or without alteplase in patients with submassive pulmonary embolism: effects on right ventricular dysfunction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2011
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Heparin
- Indications Pulmonary embolism; Right ventricular hypertrophy
- Focus Therapeutic Use
- 31 Jan 2011 Primary endpoint 'Cardiovascular-function-parameters' has been met
- 30 Jan 2011 New trial record